#pancreatic cancer

Triple Combo for Pancreatic Cancer

New study looks at clinical decision-making for pancreatic cancer surgery

Damon Runyon-Rachleff Innovator Rushika M. Perera, PhD, and colleagues may have found an answer.

“Our data support the use of platinum-based chemotherapy as first-line treatment for patients with defects in various HR genes."

A study in obese mice suggests weight loss could slow cancer growth.

This could result in better identification of the people who could benefit from screening and early detection of pancreatic cancer.

TRK inhibitor larotrectinib led to durable responses in people with colon, pancreatic, appendix, bile duct and liver cancers.

Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.

Gastrointestinal cancers conference emphasizes patient quality of life.

The Supreme Court justice recently underwent treatment for pancreatic cancer.

“I have never faced a fight quite like the one I have now,” he says.

PARP inhibitor delays disease progression when used after successful chemotherapy.

New site-agnostic therapies highlight the importance of genetic testing.

The bottom line is that people risk not having their genetic alterations identified if they do not have genetic consultations.

Jean Trebek, a practitioner of Religious Science, uses healing sound, Reiki touch and walking meditation to stay positive.

November is National Pancreatic Cancer Awareness Month.